172 related articles for article (PubMed ID: 36646019)
1. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010-2019.
Ishikawa T; Nishigori H; Akazawa M; Miyakoda K; Noda A; Ishikuro M; Metoki H; Iwama N; Saito M; Sugawara J; Kawame H; Yaegashi N; Kuriyama S; Mano N; Obara T
Pregnancy Hypertens; 2023 Mar; 31():73-83. PubMed ID: 36646019
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensives prescribed for pregnant women in Japan: Prevalence and timing determined from a database of health insurance claims.
Ishikawa T; Obara T; Nishigori H; Miyakoda K; Ishikuro M; Metoki H; Ohkubo T; Sugawara J; Yaegashi N; Akazawa M; Kuriyama S; Mano N
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1325-1334. PubMed ID: 30252182
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan.
Kikuchi D; Obara T; Miura R; Suzuki N; Hirakawa H; Josaka R; Ito M; Tokunaga M; Usui K; Okada K
Hypertens Res; 2022 Sep; 45(9):1441-1446. PubMed ID: 35715513
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Bellos I; Pergialiotis V; Papapanagiotou A; Loutradis D; Daskalakis G
Am J Obstet Gynecol; 2020 Oct; 223(4):525-537. PubMed ID: 32199925
[TBL] [Abstract][Full Text] [Related]
5. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
[TBL] [Abstract][Full Text] [Related]
6. Safety of Amlodipine in Early Pregnancy.
Mito A; Murashima A; Wada Y; Miyasato-Isoda M; Kamiya CA; Waguri M; Yoshimatsu J; Yakuwa N; Watanabe O; Suzuki T; Arata N; Mikami M; Ito S
J Am Heart Assoc; 2019 Aug; 8(15):e012093. PubMed ID: 31345083
[TBL] [Abstract][Full Text] [Related]
7. Trends in antihypertensive prescription for pregnant women with hypertension and their peripartum outcomes before and after label and guideline revisions in Japan.
Taguchi R; Shigemi D; Yasunaga H
Hypertens Res; 2022 Nov; 45(11):1823-1831. PubMed ID: 36109600
[TBL] [Abstract][Full Text] [Related]
8. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.
Li DK; Yang C; Andrade S; Tavares V; Ferber JR
BMJ; 2011 Oct; 343():d5931. PubMed ID: 22010128
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Hypertensive Disorders, Antihypertensive Therapy and Pregnancy Outcomes among Pregnant Women: A Retrospective Review of Cases at Tamale Teaching Hospital, Ghana.
Bugri AA; Gumanga SK; Yamoah P; Frimpong EK; Nlooto M
Int J Environ Res Public Health; 2023 Jun; 20(12):. PubMed ID: 37372740
[TBL] [Abstract][Full Text] [Related]
10. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
11. Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period.
Ngene NC; Moodley J
Pan Afr Med J; 2020; 36():216. PubMed ID: 32963682
[TBL] [Abstract][Full Text] [Related]
12. Risk of major congenital malformations associated with first-trimester exposure to propulsives: A health administrative database study in Japan.
Ishikawa T; Obara T; Akazawa M; Noda A; Oyanagi G; Morishita K; Miyakoda K; Nishigori H; Kawame H; Yaegashi N; Kuriyama S; Mano N
Pharmacoepidemiol Drug Saf; 2022 Feb; 31(2):196-205. PubMed ID: 34628689
[TBL] [Abstract][Full Text] [Related]
13. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
BJOG; 2016 Jun; 123(7):1143-51. PubMed ID: 26265372
[TBL] [Abstract][Full Text] [Related]
14. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
[TBL] [Abstract][Full Text] [Related]
15. Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.
Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
Pregnancy Hypertens; 2018 Jul; 13():65-71. PubMed ID: 30177074
[TBL] [Abstract][Full Text] [Related]
16. Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.
van Gelder MM; Van Bennekom CM; Louik C; Werler MM; Roeleveld N; Mitchell AA
BJOG; 2015 Jun; 122(7):1002-9. PubMed ID: 25395267
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study.
Hoeltzenbein M; Beck E; Fietz AK; Wernicke J; Zinke S; Kayser A; Padberg S; Weber-Schoendorfer C; Meister R; Schaefer C
Hypertension; 2017 Jul; 70(1):201-208. PubMed ID: 28533329
[TBL] [Abstract][Full Text] [Related]
18. Effect of antihypertensive therapy with alpha-methyldopa on uterine artery Doppler in pregnancies with hypertensive disorders.
Khalil A; Harrington K; Muttukrishna S; Jauniaux E
Ultrasound Obstet Gynecol; 2010 Jun; 35(6):688-94. PubMed ID: 20201113
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.
Abalos E; Duley L; Steyn DW; Gialdini C
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002252. PubMed ID: 30277556
[TBL] [Abstract][Full Text] [Related]
20. Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records.
Al Khalaf S; Khashan AS; Chappell LC; O'Reilly ÉJ; McCarthy FP
Hypertension; 2022 Jul; 79(7):1548-1558. PubMed ID: 35502665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
